Several health advocacy and LGBTQ organizations are urging the United States Supreme Court to uphold coverage and zero ...

Already, significant harm has been done to inhibit progress combating HIV/AIDS, and the next four years could return us to ...

This year’s Conference on Retroviruses and Opportunistic Infections (CROI) features several sessions discussing prevention ...

CRISPR technology offers innovative solutions for pandemic preparedness, enhancing diagnostics, antiviral therapies, and ...

Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) Q4 2024 Earnings Call Transcript March 6, 2025 Atea Pharmaceuticals, Inc. misses on ...

"We are ecstatic to have W-2 back on our home planet safely and are proud to support significant reentry research for our ...

Others have voiced a similar sentiment: "The staggering success in developing drugs against HIV is an example of how efficiently effective antivirals can be developed given appropriate funding".

Chimerix is currently awaiting an FDA decision on accelerated approval of a drug it’s developing for a type of glioma.

Ford’s spokesperson confirmed the news, and reports from Variety and Entertainment Weekly stated that he fell ill on February ...

Health experts have warned that a new mutant strain of mpox has been discovered and it could be more infectious than current ...

Congress did not reauthorize the rare pediatric disease priority review program at the end of 2024. Advocates say the ripple ...